Lentiviral vector PLV-PI3KCG gene transfer inhibits hypoxic cardiomyocytes apoptosis

Yan-Yan Li1, Hui Zhang2, Xin-Zheng Lu3

  • 1Department of Geriatrics, First Affiliated Hospital of Nanjing Medical University Nanjing 210029, China.

Insights

Activating the PI3K/Akt pathway protects heart cells from injury. This pathway

Area of Science:

  • Cardiovascular Biology
  • Cellular Signaling
  • Molecular Medicine

Background:

  • The PI3K/Akt signaling pathway is implicated in apoptosis.
  • Its role in inhibiting hypoxic cardiomyocyte apoptosis remains unclear.

Purpose of the Study:

  • To investigate the protective role of activated PI3K/Akt signaling in cardiomyocytes against hypoxia/reoxygenation (H/R) injury.
  • To determine if LY294002 inhibits this protective effect.

Main Methods:

  • Constructed a recombinant PI3KCG lentiviral vector (PLV-PI3KCG).
  • Transfected neonatal rat cardiomyocytes with PLV-PI3KCG to model H/R injury.
  • Utilized five experimental groups: control, H/R, HRE (empty plasmid), HRP (PLV-PI3KCG), and HRPL (PLV-PI3KCG + LY294002).

Main Results:

  • The HRP group showed significantly increased cardiomyocyte beat frequency and survival rate compared to H/R, HRE, and HRPL groups (P<0.05).
  • LDH release was significantly decreased in the HRP group (P<0.05).
  • The Bcl-2/Bax ratio was significantly lower in H/R, HRE, and HRPL groups than in the HRP group (P<0.05).

Conclusions:

  • Activated PI3K/Akt signaling pathway plays a protective role in cardiomyocyte H/R injury.
  • LY294002, an inhibitor, can block this protective effect.

Related Concept Videos